Red cell transfusion thresholds in myelodysplastic syndromes: a clinician survey to inform future clinical trials

Allison Mo, Zoe K. McQuilten, Erica M. Wood, Robert Weinkove

Research output: Contribution to journalArticleResearchpeer-review

18 Citations (Scopus)


Optimal red cell transfusion thresholds in myelodysplastic syndrome are not established. In this survey of 110 Australasian haematologists’ practice in myelodysplastic syndrome-related anaemia, 92% of respondents set transfusion thresholds, and would typically transfuse at a haemoglobin <80 g/L aiming for a post-transfusion haemoglobin 90–100 g/L, reflecting a restrictive transfusion strategy. Higher thresholds were typically used for patients with cardiovascular disease or anaemia symptoms. These results will inform the design of clinical trials comparing transfusion thresholds.

Original languageEnglish
Pages (from-to)695-698
Number of pages4
JournalInternal Medicine Journal
Issue number6
Publication statusPublished - 1 Jun 2017


  • anaemia
  • haemoglobin
  • myelodysplastic syndrome
  • survey
  • transfusion

Cite this